Stepping Back Up Amid COVID-19

September 18, 2020
New data from 23andMe shows that although people became less active early in the COVID-19 pandemic, activity-levels measured in steps have gone back up.
Read More

23andMe COVID-19 Study Findings Published

September 09, 2020
This week 23andMe scientists published findings from the first four months of our COVID-19 study using data from more than a million research participants that found both genetic and non-genetic...
Read More

Study Highlights How Common Genetic Variants Are that Impact Drug Processing

September 08, 2020
A majority of people have at least one genetic variant in the CYP2C19 gene that may alter how their bodies process commonly prescribed drugs.
Read More

Making Good of Your Time

September 02, 2020
Jamie's experience volunteering at Camp Champ helped to lead 23andMe to add a new Volunteer Time Off benefit for all its employees.
Read More

At 23andMe It Starts with Privacy

August 26, 2020
Securing and protecting that data is paramount to 23andMe. We're committed to keeping our customers' trust and providing a secure place where they can explore their DNA, knowing their privacy is protected. That starts with giving our customers a choice in whether their data is shared. We also want our customers to clearly understand how their data might be used if they choose to share it, and by whom.
Read More

New Insights from Lupus Research

August 24, 2020
23andMe shares insights from its Lupus Research Study, one of the largest genetic studies of the condition to date. Although the study did not find any new genetic associations, the research did reveal new details on symptoms, and associated conditions.
Read More

FDA grants 23andMe clearance to offer interpretive drug information for two medications

August 18, 2020
The FDA granted 23andMe clearance to offer a pharmacogentics report on two commonly prescribed medications, one prescribed for heart conditions, and the other for depression.
Read More

Social Distancing during COVID-19 — Who, When, Where

August 11, 2020
23andMe’s research into COVID-19 reveals that amid the pandemic between April and June, adherence to social distancing measures waned, only to go back up in July as cases spiked again.
Read More

23andMe to Study Idiopathic Pulmonary Fibrosis

August 10, 2020
23andMe launched a genetic study of Idiopathic Pulmonary Fibrosis (IPF), a rare disease that results in scarring of the lungs. There is currently no cure.
Read More

Racial and Ethnic Disparities in Impact of COVID-19

August 06, 2020
Blacks and Latinos are disproportionately affected by COVID-19, according to new data from scientists at 23andMe, illustrating the racial disparities in the impact of the virus.
Read More